Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines

05.08.2008 21:40:06
Abbott Laboratories: Mexico City (ots/PRNewswire) - - HIV-Infected Women and Non-Whites New to Antiretroviral Therapy Respond Similarly to Men and Whites Initial treatment regimens containing once-daily or twice-daily dosing of Abbott's (NYSE: ...

Lesen Sie hier weiter... |  Drucken |  PDF

Ähnliche Artikel




Abbott's Kaletra(R) Tablet Dosed Once-Daily Or Twice-Daily Demonstrated ...

Abbotts KaletraR Tablet Dosed Once,Daily Or Twice,Daily Demonstrated Similar Clinical Results Across Race And Gender Lines , Pharmaceutical News


2008 August 05 | Aktuelle News aus Deutschland und der Welt

ots: Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines.Mexico City (ots


ots.at: das APA-OTS-Portal für multimediale Presseaussendungen

Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results.Across Race and Gender Lines = 05.08.2008 / 21:28


Presseportal: Abbott Laboratories - Abbott kündigt Zulassung für ersten ...

Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines


Die Physiker der Universität von KwaZulu-Natal gehen als die Gründert ...

Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines